HLA-DRB1 and myeloid sarcoma: A comparison of the clinical characteristics of MS patients with HLA-DRB1*04:05 between northern and southern Japan showed that southern patients had a milder disease course and atypical presentation including episodes of transverse myelitis and having ANA, which may result in the lower frequency of DMD treatment.